Isomorphic Labs
PrivateLast Round
Series B
May 12, 2026
Est. Valuation
$17.5B
Total Funding Raised
$2.94B
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Isomorphic Labs is a biotechnology company that uses an AI-first approach to reimagine the drug discovery process.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isomorphic Labs Comparables
Compare Isomorphic Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 84% | |
| Generate Biomedicines | 83% | |
| BenevolentAI | 81% |
Isomorphic Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 12, 2026 | ||||
| Series A | Mar 31, 2025 | ||||
| Corporate Funding | Sep 18, 2024 | ||||
| Spinoff | Nov 4, 2021 |
Isomorphic Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UK Department for Science, Innovation and Technology | Series B |
| Temasek | Series B |
| GV | Series B, Series A |
| Thrive Capital | Series B, Series A |
| CapitalG | Series B |
| MGX | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 89% MoM.
- May 12, 2026
$2.0B raised, led by Thrive Capital.
Isomorphic Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessAppears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about Isomorphic Labs's valuation, stock price, and market status.
Is Isomorphic Labs a public or private company?
Isomorphic Labs is a private company.
What is the current stock price of Isomorphic Labs?
Isomorphic Labs is a private company with no public stock price. Caplight tracks Isomorphic Labs's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Isomorphic Labs worth (valuation)?
Isomorphic Labs's valuation is estimated at $17.5B based on funding round data.
Can I buy Isomorphic Labs stock?
Isomorphic Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Isomorphic Labs's last funding round?
Isomorphic Labs's most recent funding round was Series B on May 12, 2026.
Who are the main investors in Isomorphic Labs?
Key investors in Isomorphic Labs include Thrive Capital.
Will Isomorphic Labs IPO soon?
No public IPO plans have been announced for Isomorphic Labs.
How can I track Isomorphic Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Isomorphic Labs's secondary market activity and sign up for updates.